Thus, we used the proteins in lysates derived from cultured glioma (SW1088), glioblastoma (A172), and neuroblastoma (SH-SY5Y) cell lines to evaluate the expression of MCC by immunoblotting analysis with the antibodies against MCC. Here, MCC is linked to central nervous system cancer.